Merck Announces New Data from Broad HIV Program at CROI 2020
Dateline City:
KENILWORTH, N.J.
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today the presentation of new data from its ongoing HIV research programs at the Conference on Retroviruses and Opportunistic Infections (CROI 2020) taking place March 8 – 11, 2020 in Boston, Massachusetts.
Language:
English
Contact:
Media Contacts:
Pamela Eisele
(267) 305-3558
Sarra S. Herzog
(908) 740-1871
Investor Contacts:
Peter Dannenbaum
(908) 740-1037
Michael DeCarbo
(908) 740-1807
Ticker Slug:
Ticker:
MRK
Exchange:
NYSE
@Merck
Read Original Article: Merck Announces New Data from Broad HIV Program at CROI 2020 »
